S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:REGN

Regeneron Pharmaceuticals SEC Filings & 10K Form

$635.16
+1.16 (+0.18%)
(As of 12/3/2021 04:00 PM ET)
Add
Compare
Today's Range
$623.12
$641.79
50-Day Range
$543.48
$654.40
52-Week Range
$441.00
$686.62
Volume
649,654 shs
Average Volume
847,466 shs
Market Capitalization
$68.31 billion
P/E Ratio
10.14
Dividend Yield
N/A
Beta
0.19

Regeneron Pharmaceuticals (NASDAQ:REGN) SEC Filings

DateFilerForm TypeView
09/15/2021
3:03 PM
BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2021
3:03 PM
Regeneron Pharmaceuticals (Issuer)
Zoghbi Huda Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2021
3:02 PM
Regeneron Pharmaceuticals (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
3:05 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2021
3:01 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2021
3:06 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4/A
08/17/2021
3:17 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2021
3:16 PM
Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2021
4:19 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:55 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:54 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:00 PM
BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:00 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2021
6:11 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2021
5:59 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2021
3:03 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2021
3:01 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
3:03 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
3:03 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
3:02 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
6:21 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2021
6:12 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2021
6:12 AM
Regeneron Pharmaceuticals (Filer)
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2021
3:21 PM
Regeneron Pharmaceuticals (Filer)
Form DEFA14A
04/23/2021
3:16 PM
Regeneron Pharmaceuticals (Filer)
Form DEFA14A
02/18/2021
3:01 PM
Decibel Therapeutics, Inc. (Issuer)
Regeneron Pharmaceuticals (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2021
4:01 PM
Decibel Therapeutics, Inc. (Issuer)
Regeneron Pharmaceuticals (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/10/2021
10:47 AM
Regeneron Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2021
8:13 AM
Regeneron Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2021
6:34 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2021
7:23 AM
BlackRock Inc. (Filed by)
Regeneron Pharmaceuticals (Subject)
Form SC 13G/A
01/15/2021
3:01 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2021
5:03 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
3:09 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
3:07 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
3:04 PM
Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:03 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2020
4:30 PM
Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:07 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:06 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:06 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:05 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:05 PM
Regeneron Pharmaceuticals (Issuer)
STAHL NEIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:05 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:04 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:03 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:09 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
3:02 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2020
4:57 PM
COLES N ANTHONY (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
6:48 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
6:32 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2020
4:22 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2020
3:02 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
3:09 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
3:07 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
3:13 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2020
3:01 PM
BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2020
3:00 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:18 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
3:37 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
3:36 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
3:35 PM
POON CHRISTINE A (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2020
3:23 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2020
3:21 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
5:14 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
5:13 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
4:19 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
3:47 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
5:00 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2020
3:02 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2020
3:32 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
8:37 PM
Regeneron Pharmaceuticals (Filer)
Form 424B5
08/07/2020
3:48 PM
Regeneron Pharmaceuticals (Subject)
Form FWP
08/07/2020
8:27 AM
Regeneron Pharmaceuticals (Filer)
Form 424B3
08/05/2020
4:09 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:07 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
6:36 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2020
6:15 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2020
3:31 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2020
3:30 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2020
3:51 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2020
3:51 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2020
8:40 AM
Regeneron Pharmaceuticals (Filer)
Form CT ORDER
07/14/2020
3:17 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2020
3:29 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2020
3:16 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2020
3:14 PM
Regeneron Pharmaceuticals (Issuer)
Zoghbi Huda Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2020
6:28 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
3:02 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
3:08 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
3:03 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:10 PM
Regeneron Pharmaceuticals (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC 13D/A
06/16/2020
3:33 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2020
3:03 PM
Regeneron Pharmaceuticals (Issuer)
Zoghbi Huda Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:01 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
5:45 PM
Regeneron Pharmaceuticals (Issuer)
Sanofi (Reporting)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
9:13 AM
FMR LLC (Filed by)
Regeneron Pharmaceuticals (Subject)
Form SC 13G
06/08/2020
7:47 AM
Regeneron Pharmaceuticals (Filer)
Form DEFA14A
05/28/2020
2:50 PM
Regeneron Pharmaceuticals (Filer)
Form 424B3
05/26/2020
5:16 AM
Regeneron Pharmaceuticals (Filer)
Form 424B3
This page was last updated on 12/5/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.